ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)

Manufacturer
Fenwal, Inc. | Fenwal International, Inc.
Effective date
2019-11-26
Label type
Human Prescription Drug Label
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 23:57:02

Label at a glance#

ProductADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)
Active ingredientTrisodium Citrate Dihydrate, Dextrose Monohydrate, Anhydrous Citric Acid, Sodium Phosphate, Monobasic, Monohydrate, Sodium Chloride, Mannitol, Adenine
Label structure2 sections

Label contents#

Full prescribing information#

Instructions for Blood Collection Using CPD OPTIPAC™ Unit with an Integrally Attached Container of ADSOL™ Red Cell Preservation Solution

SPL UNCLASSIFIED SECTION

Rx Only

Opti-System

Use aseptic technique

Caution: Do not use unless the solutions are clear.

  • Identify BLOOD-PACK™ OPTIPAC™ unit using appropriate donor identification system.
  • Adjust donor scale to desired collection weight/volume.
  • Suspend primary container from donor scale as far as possible below donor arm and clamp donor tubing with hemostat.
  • Apply pressure to donor’s arm and disinfect site of venipuncture.
  • If blood pressure cuff is used, inflate to approximately 60 mm Hg, or use tourniquet as applicable.
  • Remove needle cover per instructions below:
    1. Hold the needle hub upwards. With the other hand, grasp the base of the needle cover (Figure 1), twist approximately 1/4 turn to break tamper evident seal (Figure 2).
    2. Remove needle cover (Figure 3), be careful not to drag cover across the needle point (Figure 4).
  • Perform venipuncture, appropriately secure donor needle and/or tubing and release hemostat.
  • Mix blood and anticoagulant at several intervals during collection and immediately after collection.
  • Collect labeled volume of blood. Anticoagulant volume is sufficient for labeled volume ± 10%.
  • Apply hemostat to donor tubing.
  • If it is necessary, obtain whole anticoagulated blood samples for typing or crossmatching by returning donor tubing blood to the primary bag, mixing and allowing tubing to refill. Repeat once. Seal donor tubing at the desired intervals in order to obtain the desired total blood samples.
  • Centrifuge primary and secondary bags in order to prepare CPD Red Blood Cells.
  • Refer to the OPTIPRESS™ Blood Components Automated Extractor User Manual, in order to prepare the components.
  • After separation, seal transfer tubing in three places near the primary bag and cut middle seal taking care to avoid fluid splatter.
    NOTE: In OPTIPAC Quadruple BLOOD-PACK unit, the empty transfer unit may be used for preparation of other components.
  • Fill empty tubing of OPTIPAC AS-1 for red blood cells by stripping the tubing and mixing the AS-1 containter, twice, in order to ensure that the tubing is correctly filled. Seal on "X" marks on tubing in order to obtain red blood cells samples.
  • Mix Adsol Solution and red cells thoroughly.
  • Store suspended Red Blood Cells between 1 and 6 °C.

For further processing, use standard techniques for component processing.

Sterile, non-pyrogenic fluid path. Sterilized by steam. Single use only. Dispose of container appropriately.

Store at Controlled Room Temperature
USP Definition of “Controlled Room Temperature”
United States Pharmacopeia, General Notices.
United States Pharmacopeial Convention, Inc.
12601 Twinbrook Parkway, Rockville, MD

Representative Product Drawings
Representative Product Drawings

logologoManufactured by:
Fenwal International, Inc.
Road 357, Km. 0.8
Maricao, PR 00606

Made in USA

07-19-05-015    REV: A
07/2010

Imported and distributed in Indonesia by:
PT.Medquest Jaya Global
Menara Salemba 6th Floor
Jl.Salemba Raya Kav 5-5A
Jakarta-Indonesia 10440
Reg. No.: DEPKES RI AKL 20209902359

Imported and distributed in Thailand by:
Fenwal (Thailand) Ltd.
17th Fl. Thanapoom Tower
1550 New Petchburi Rd., Makasan
Rajthevi, Bangkok 10400
Thailand
Reg. No.:

Imported and distributed in Philippines by:
Medlink Marketing
Unit 404 Vicar’s Building,
No.31 Visayas Ave.,
Vasra, Quezon City 1100
Philippines
Reg. No.: DVR-5805

logologo– Manufacturer

FENWAL, ADSOL, BLOOD-PACK, OPTIPAC and OPTIPRESS are trademarks of Fenwal, Inc.

© 2010 Fenwal, Inc. All rights reserved.

PACKAGE/LABEL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Code A4R7703

5 Units

Fenwal™

Quadruple BLOOD-PACK™ OPTIPAC™ Unit CPD/ADSOL™ OPTI-SYSTEM™

Rx only

Quadruple BLOOD-PACK OPTIPAC unit consisting of a primary pack containing 63 mL of CPD anticoagulant solution for collection of 450 mL of blood, one TRANSFER-PACK containing 100 mL of ADSOL solution and two TRANSFER-PACK containers without solution. 16 gauge needle.

Each 63 mL of CPD solution contains: 1.66 g, Sodium citrate (dihydrate), USP, 1.61 g Dextrose (monohydrate), USP, 188 mg Citric acid (anhydrous), USP, 140 mg Monobasic sodium phosphate (monohydrate), USP. Water for Injection USP to 63 mL

Each 100 mL of ADSOL solution contains: 2.20 g Dextrose (monohydrate), USP - 900 mg Sodium Chloride (monohydrate,) USP - 750 mg Mannitol, USP - 27.0 mg Adenine, USP. Water for injection USP to 100 mL.

See instructions for use. Sterile, non-pyrogenic fluid path. Steam sterilized. Single use only. Do not vent. Do not use if there is visible evidence of deterioration. Dispose of container properly.

Store at Controlled Room Temperature
(refer to direction insert).

Unused units in open foil pouch may be kept up to 60 days by folding and securing open end of foil pouch to prevent possible loss of moisture.

Direct handling of product surfaces prior to extended storage in the foil pouch may result in mold growth.

Units removed from the foil pouch must be used within 4 days (96 hours). Units out of the foil pouch for longer than 4 days must be discarded.

logologoManufactured by:
Fenwal International, Inc.
Road 357, Km. 0.8
Maricao, PR 00606

Made in USA

Imported and distributed in Thailand by:
Fenwal (Thailand) Ltd.
17th Fl. Thanapoom Tower
1550 New Petchburi Rd., Makasan
Rajthevi, Bangkok 10400
Thailand

Imported and distributed in Indonesia by:
PT.Medquest Jaya Global
Menara Salemba 6th Floor
Jl.Salemba Raya Kav 5-5A
Jakarta-Indonesia 10440
Reg. No.: DEPKES RI AKL 20209902359

FENWAL, BLOOD-PACK, ADSOL, OPTIPAC and OPTI-SYSTEM are trademarks of Fenwal, Inc.

07-28-05-406    REV: A

Lot No.:

Exp. Date:

Quadruple BLOOD-PACK™ OPTIPAC™ Unit CPD/ADSOL™ OPTI-SYSTEM™ label
Quadruple BLOOD-PACK™ OPTIPAC™ Unit CPD/ADSOL™ OPTI-SYSTEM™ label

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AdenineACTIVE INGREDIENTJAC85A21612
Anhydrous Citric AcidACTIVE INGREDIENTXF417D3PSL2
Dextrose MonohydrateACTIVE INGREDIENTLX22YL083G2
MannitolACTIVE INGREDIENT3OWL53L36A2
Sodium ChlorideACTIVE INGREDIENT451W47IQ8X2
Sodium Phosphate, Monobasic, MonohydrateACTIVE INGREDIENT593YOG76RN2
Trisodium Citrate DihydrateACTIVE INGREDIENTB22547B95K2
AdenineACTIVE MOIETYJAC85A21612
Anhydrous Citric AcidACTIVE MOIETYXF417D3PSL2
ANHYDROUS DEXTROSEACTIVE MOIETY5SL0G7R0OK2
MannitolACTIVE MOIETY3OWL53L36A2
PHOSPHATE IONACTIVE MOIETYNK08V8K8HR2
SODIUM CATIONACTIVE MOIETYLYR4M0NH372

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0942-65020942-6502-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d7e30e3a-7253-461b-88e2-8227b3211ab4cdfc37e7-c6c5-4e2a-b773-90f793decb562021-09-16Exact identifier
spl set id: cdfc37e7-c6c5-4e2a-b773-90f793decb56

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.